Large language model analysis of real-world phone calls reveals prodromal and progressive biomarker of parkinsonism: A two-year proof-of-concept study
{{output}}
No sufficiently sensitive biomarker exists to monitor disease progression to assess treatment efficacy in synucleinopathies such as Parkinson's disease (PD), particularly during the prodromal phase when interventions are likely to be most effective. Existing ... ...
